Vivo Bio Tech Board Approves AGM, Director Re-appointments

Vivo Bio Tech Ltd announced the outcome of its Board Meeting held on August 22, 2026. The board approved the 39th Annual General Meeting (AGM) to be held on September 30, 2026, via Video Conferencing. Key approvals also include the Board's Report, Corporate Governance Report, and Management Discussion and Analysis for the financial year ended March 31, 2026. Furthermore, the re-appointment of Mr. Kalyan Ram Mangipudi as Whole-Time Director was approved, retiring by rotation. The board also approved the re-appointment of Mr. Sri Kalyan Kompella and Dr. Sankaranarayanan Alangudi as Whole-Time Directors for five-year terms, subject to shareholder approval.